$216 Million Obligated to New Jersey for COVID-19 Vaccination Costs

Release Date Release Number
Release Date:
January 26, 2021

NEW YORK – The Federal Emergency Management Agency has obligated $216 million to New Jersey for costs related to the COVID-19 vaccine mission.

The award provides $216,000,000 in federal funding to the New Jersey State Police (NJSP) to reimburse costs associated with emergency protective measures taken by the state to store, handle, transport, distribute and administer vaccines to reduce the spread the of the virus.

The Coronavirus Disease 2019 (COVID-19) pandemic created an immediate threat to the health and safety of the general public requiring emergency response and protective measures throughout the State of Jersey.  To help control the spread of the COVID-19 virus, the State of New Jersey, represented by the NJSP, acting in partnership with the NJ Department of Health, is distributing and administering COVID-19 vaccines to its population. The NJSP are managing six (6) vaccination mega sites across the entire state. This is in addition to dozens of other access points including private hospitals, pharmacies, and community-based vaccination sites run by multiple counties with state oversight.

Grants for emergency protective measures are funded through FEMA’s Public Assistance program, which reimburses communities for actions taken in the immediate response and during recovery from a disaster. Eligible applicants include states, federally recognized tribal governments, U.S. territories, local governments and certain private non-profit organizations. 

If you have any questions, please contact FEMA Region 2 Office of External Affairs at (347) 416-3792 or at fema-r2-externalaffairs@fema.dhs.gov.  

FEMA’s mission is helping people before, during, and after disasters. FEMA Region 2’s jurisdiction includes New York, New Jersey, Puerto Rico and the United States Virgin Islands.

 Follow us on Twitter at twitter.com/femaregion2.

Last updated